Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept: Daeun Shin, Jae Hui Kim; J Korean Ophthalmol Soc. 2022;63(6):526-534. Published online June 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.6.526; Full text PubReader ePub Crossref - TDM PDF

Association between Vortex Vein Engorgement and Treatment Outcomes of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Areum Jeong, Min Sagong; J Korean Ophthalmol Soc. 2021;62(10):1370-1380. Published online October 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.10.1370; Full text PubReader ePub Crossref - TDM PDF

Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration: Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(9):1218-1226. Published online September 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.9.1218; Full text PubReader ePub Crossref - TDM PDF

Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration: Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(8):1076-1083. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1076; Full text PubReader ePub Crossref - TDM PDF

Comparison of Intravitreal Bevacizumab and Aflibercept Injections for Central Serous Chorioretinopathy: Min Soo Park, Seung Joon Lee; J Korean Ophthalmol Soc. 2021;62(7):957-962. Published online July 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.7.957; Full text PubReader ePub Crossref - TDM PDF

Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema.: Jangmi Yang, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(7):667-675. Published online July 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.7.667
Cited By 3; PDF

Use of Anti-vascular Endothelial Growth Factors for Diabetic Retnopathy: National Health Insurance Claims Data.: Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(7):661-666. Published online July 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.7.661
Cited By 9; PDF

Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept.: Tae Kyu Moon, Jun Young Ha, Mi Sun Sung, Sang Woo Park; J Korean Ophthalmol Soc. 2019;60(4):362-368. Published online April 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.4.362; PDF

Meta-analysis of Intravitreal Injection of Anti-vascular Endothelial Growth Factors for Diabetic Macular Edema.: Hajin Tchoe, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(2):144-151. Published online February 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.2.144; PDF

Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration.: In Ho Lee, Jae Jung Lee, Han Jo Kwon, Sung Who Park, Ji Eun Lee; J Korean Ophthalmol Soc. 2019;60(1):40-46. Published online January 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.1.40
Cited By 4; PDF

Case Reports

A Case of Choroidal Osteoma with Subretinal Hemorrhage Improved by Intravitreal Bevacizumab and Aflibercept Injections.: Charm Kim, Kyung Seek Choi, Hae Jung Sun; J Korean Ophthalmol Soc. 2018;59(10):989-994. Published online October 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.10.989; PDF

Rapid Progression of the Epiretinal Membrane after Intravitreal Aflibercept Injection.: Ji Min Kwon, Myung Shin Lee, Kang Yeun Pak, Hyun Woong Kim; J Korean Ophthalmol Soc. 2018;59(10):984-988. Published online October 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.10.984; PDF

Original Articles

Intravitreal Aflibercept Monotherapy for Treating Submacular Hemorrhage Secondary to Neovascular Age-related Macular Degeneration.: Sue Hey Chae, Soh Eun Ahn, Hee Seong Yoon; J Korean Ophthalmol Soc. 2018;59(5):437-443. Published online May 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.5.437; PDF

Long-term Treatment Outcome of Intravitreal Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy.: Ye Ji Kim, Sang Yun Han, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jae Hui Kim; J Korean Ophthalmol Soc. 2018;59(3):238-245. Published online March 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.3.238
Cited By 2; PDF

A Comparison of Efficacies of Aflibercept and Ranibizumab, Depending on the Angiographic Classification of Polypoidal Choroidal Vasculopathy.: Gahyung Ryu, Donghyoun Noh, Junyeop Lee, Min Sagong; J Korean Ophthalmol Soc. 2017;58(12):1356-1366. Published online December 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.12.1356; PDF

Volume 63, No. 6

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

MOST VIEWED MOST CITED

1,639	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
1,187	A Study of Entropion Occurred after Lower Eyelid Cosmetic Surgery
1,129	Impact of Social Distancing and Personal Hygiene on the Prevalence of Epidemic Keratoconjunctivitis during the COVID-19 Pandemic
1,881	Accidental Swallowing of Nasal Packing Gauze during Silicone Tube Intubation under Local Anesthesia
1,721	Efficacy of Preservative-free Latanoprost in Normal-tension Glaucoma with Mild to Moderate Dry Eye

Cited By 6	Short-term Outcomes and Prognostic Factors of iStent in the Republic of Korea
Cited By 5	Association between Dry Eye Questionnaires and Dry Eye Sign in Meibomian Gland Dysfunction.
Cited By 4	Measuring Defocus Curves of Monofocal, Multifocal and Extended Depth-of-focus Intraocular Lenses Using Optical Bench Test.
Cited By 4	Clinical Aspects of Phlyctenular Keratoconjunctivitis Using a Tear Film Interferometer.
Cited By 4	Efficacy of Preservative-free Latanoprost in Normal-tension Glaucoma with Mild to Moderate Dry Eye

Editorial Office: SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520 Fax: +82-2-583-6521 E-mail: kos08@ophthalmology.org

Copyright © 2022 by Korean Ophthalmological Society.

prev

next